In these GO terms, non-receptor-type protein phosphatase 1 (PTPN1), mediating AD-like tau pathology in the hippocampus of wild-type mice and synaptic and memory disorders in AD (Hou et al., 2020), was potentially targeted by miR-149, which was downregulated at 10 DPI. The gene discussed is MAPT; the disease is Alzheimer disease.